Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neoadjuvant induction chemotherapy.

G Schwartz1

  • 1Department of Surgery, Jefferson Medical College Philadelphia, PA, USA. gordonschwartz@yahoo.com

Minerva Ginecologica
|September 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seedling rescue from natural regeneration and use of Osmocote for production of Jacaranda copaia (Aubl.) D. Don seedlings.

Brazilian journal of biology = Revista brasleira de biologia·2026
Same author

Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma.

ESMO open·2026
Same author

Osmocote accelerates seedling development and quality of the slow-growing species Vouacapoua americana Aubl.

Brazilian journal of biology = Revista brasleira de biologia·2026
Same author

Author Correction: Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

Nature ecology & evolution·2026
Same author

Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

Nature ecology & evolution·2026
Same author

Seedling quality of Cordia trichotoma under different container volumes and fertilizers.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same journal

High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.

Minerva ginecologica·2021
Same journal

Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.

Minerva ginecologica·2020
Same journal

[Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].

Minerva ginecologica·2020
Same journal

Update on new imaging technologies in sentinel node detection.

Minerva ginecologica·2020
Same journal

Postoperative pelvic dysfunctions associated with the reconstruction of the pelvic floor.

Minerva ginecologica·2020
Same journal

The role of sentinel-node biopsy in ovarian cancer.

Minerva ginecologica·2020
See all related articles

Neoadjuvant chemotherapy (NACT) and hormonal therapy (NAHT) are standard breast cancer treatments. Achieving a complete pathological response (pCR) with NACT improves patient outcomes, with Herceptin showing promise in enhancing pCR rates.

Area of Science:

  • Oncology
  • Breast Cancer Research
  • Chemotherapy

Background:

  • Neoadjuvant chemotherapy (NACT) and neoadjuvant hormonal therapy (NAHT) are established treatments for locally advanced breast cancer.
  • NACT initially aimed to reduce tumor size for surgical eligibility, later facilitating breast conservation.
  • While overall survival benefits are debated, NACT shows promise in improving disease-free survival and reducing local recurrence.

Purpose of the Study:

  • To review the current role and controversies surrounding neoadjuvant therapy in breast cancer treatment.
  • To explore the significance of pathological response in predicting patient outcomes.
  • To highlight emerging strategies and future directions in neoadjuvant breast cancer care.

Main Methods:

  • Review of clinical trial data and prospective studies on neoadjuvant therapy for breast cancer.

Related Experiment Videos

  • Analysis of treatment outcomes, including tumor response, survival rates, and recurrence.
  • Discussion of controversies regarding sentinel lymph node biopsy (SLNB) post-NACT and treatment for smaller tumors.

    • Main Results:

    • NACT enables breast conservation in a majority of patients.
    • Clinical trial data suggest NACT does not significantly impact overall survival, but prospective data indicate improved survival and reduced recurrence.
    • Complete pathological response (pCR) to NACT is associated with improved patient outcomes.
    • Adding Herceptin to NACT regimens has shown an increased rate of pCR.

    Conclusions:

    • NACT plays a crucial role in breast cancer management, particularly in enabling breast conservation.
    • Achieving pCR is a key indicator of treatment success and improved outcomes.
    • Ongoing research into optimizing NACT regimens, including the addition of targeted therapies like Herceptin, is vital for enhancing pCR rates and expanding NACT applicability to earlier-stage cancers.